Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Octylphenol Polyoxyethylene Ether 9, known in the industry under the abbreviation OP-9, belongs to the group of nonionic surfactants formed by reacting octylphenol with eight to ten ethylene oxide units. Manufacturers tap into its properties for the pharmaceutical sector under rigorous BP, EP, and USP Pharma Grade standards. The molecular formula stands as C24H42O10, reflecting a balance of hydrophilic and hydrophobic elements. Each batch gets tested against strict chemical and microbiological limits to guarantee patient safety and consistent function.
In practice, OP-9 presents itself as a waxy solid at room temperature, offering mild flexibility under pressure. Some shipments come as small flakes, powders, pearls, or solidified blocks, based on supplier specifications and intended pharmaceutical use. Liquid forms exist at higher temperature or in concentrated solution, favoring dissolution into aqueous phases. Density lands near 1.05 g/cm3, and the melting point ranges from 42°C to 46°C, giving handling staff a clue about storage and transport. Value comes from real hands-on experience; in laboratory work, the texture of the material, how it responds to moderate heat or cooling, and how it blends with water all tell much about purity and chemical consistency from batch to batch.
The OP-9 molecule features a branched hydrophobic octylphenol moiety and a hydrophilic polyoxyethylene chain, granting it surfactant properties. This duality brings emulsification, wetting, and dispersing action in water-based pharmaceutical formulations. In personal lab work, reliable surfactancy reduces granule clumping and boosts tablet consistency — product loss drops and patient outcomes improve. Hydroxyl functional groups tie to the ethylene oxide units, enabling hydrogen bonding. With a specific molecular weight of approximately 482, pharmaceutical technologists often cite this figure when planning dosing, blending, and compatibility checks. The HS Code 340213 provides the official customs identifier, allowing smooth global transit and regulatory compliance.
Raw OP-9 can cause mild irritation to skin and eye tissue with prolonged direct contact. Safety data sheets warn users to employ gloves, goggles, and fume control where dust or concentrated solutions get prepared. Material storage takes place in cool, dry areas within sealed containers, away from food and incompatible chemicals. While not classified as a severe acute toxin, repeated exposure without personal protective equipment (PPE) over weeks — as seen in some poorly managed production environments — may trigger dermatitis or mild respiratory complaints. Strict regulation over handling and disposal speaks to a hard lesson: careless storage leads to environmental contamination, as surfactants do not readily degrade and can harm aquatic systems. Thus, working with OP-9 means following best safety practices not just for regulatory reasons, but out of practical necessity to protect health and the workspace.
Products graded for pharma use must reach high standards for purity, solubility, microbial count, and elemental impurities. Spec sheets usually define minimum active content (OP-9) and cap heavy metals far below 10 ppm. Water solubility shows up above 90% at room temperature. In practical blending, this ensures OP-9 disperses rapidly, reducing risk of clumping and making active pharmaceutical ingredients more bioavailable. Manufacturing runs apply in-line sensors to monitor bulk density in tons of powder, avoiding inconsistent tablet performance seen with lower-grade surfactants. Each lot carries a certificate of analysis, with batch traceability maintained by laboratory managers through a digital management system.
Pharmaceutical factories and compounding pharmacies trust OP-9 because it serves a distinct role as an excipient, emulsifying agent, and stabilizer for active drugs that challenge conventional solubility. The value comes not only in what the molecule does, but how it helps costly active ingredients deliver predictable therapy per dose. Reaching USP, BP, and EP grade reflects not paperwork but investment in pure, screened, and repeatably manufactured input. My own time spent tracking down sources for nonionic surfactants often involved elimination of cheaper alternatives—many failed after hitting hurdles with lot-to-lot purity or inconsistent physical state. The high bar of pharma grade ensures that workarounds and costly reformulations rarely occur, streamlining both scale-up and regulatory submissions for new drugs and generics alike.
Experience in production settings emphasizes the reality—risk comes not just from the chemical itself, but also from poor planning and oversight. OP-9 needs closed transfer systems and regular housekeeping to keep workplace air and benches clean. At the environmental level, plants must capture any waste and treat water streams, preventing firewater runoff if accidents hit. This means investment in in-plant wastewater treatment and monitoring, backed up by real data on outflow and compliance checks. Adopting safer containers, lighter packaging, and returnable tote systems measurably cut chemical loss and off-site contamination during transport and delivery. Industry-wide, collaboration with government and environmental agencies strengthens practical safety programs, helping build trust with patients and local communities.
Ongoing work in the market seeks surfactants with lower environmental persistence and reduced human risk without giving up reliability. Research teams look at modified ether chains or biodegradable substitutes, chasing the right balance of affordability, stability, and process compatibility. Transitioning from legacy materials to safer, greener replacements doesn't just serve compliance or public relations; it benefits production teams and end-users alike. Proper data sharing between chemical makers, pharmaceutical producers, and medical professionals helps guide better choices and faster replacement of outdated technology.
Chengguan District, Lanzhou, Gansu, China
